Luciana Molinero to Disease-Free Survival
This is a "connection" page, showing publications Luciana Molinero has written about Disease-Free Survival.
Connection Strength
0.075
-
Peri-operative atezolizumab in early-stage triple-negative breast cancer: final results and ctDNA analyses from the randomized phase 3 IMpassion031 trial. Nat Med. 2025 Jul; 31(7):2397-2404.
Score: 0.048
-
Gene Expression Profiling in BRAF-Mutated Melanoma Reveals Patient Subgroups with Poor Outcomes to Vemurafenib That May Be Overcome by Cobimetinib Plus Vemurafenib. Clin Cancer Res. 2017 Sep 01; 23(17):5238-5245.
Score: 0.027